FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's supplemental application for INDOMETHACIN, marking an approved modification to the product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Gout
• Osteoarthritis
• Patent Ductus Arteriosus
• Rheumatoid Arthritis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOMETHACIN (INDOMETHACIN)